Literaturverzeichnis

[Fenchurch]

Ich habe ein Problem mit dem PDF Output meines Literaturverzeichnis.

Es sieht so aus:
[4] S. S. Bolz, L. Vogel, D. Sollinger, R. Derwand, C. de Wit, G. Loirand, and
U. Pohl. Nitric oxide-induced decrease in calcium sensitivity of resistance
arteries is attributable to activation of the myosin light chain phosphatase
and antagonized by the rhoa/rho kinase pathway. Circulation, 107(24):3081–
7, 2003. 1524-4539 Journal Article.


Der artikel heisst aber eigenlich: Nitric oxide-induced decrease in calcium sensitivity of resistance arteries is attributable to activation of the myosin light chain phosphatase and antagonized by the RhoA/Rho kinase pathway.

Und so steht er auch in der datei.bib

Außerdem sollte der letze Satz: 1524-4539 Journal Article. nicht dabei stehen.

Mein Befehl für mein Literaturverzeichnis ist:
\bibliographystyle{plain}

weiss jemand was ich da falsch mache?

Danke Katrin

[rais]

Hallo Katrin,
setz' den Teil `RhoA/Rho' mal in geschweifte Klammern (bzw. alles, was auch gross geschrieben werden soll).
MfG,

[Fenchurch]

Funktioniert leider nicht....

hier der orginal BibTex Eintrag:

Bolz2003
@article{
Bolz2003,
Author = {Bolz, S. S. and Vogel, L. and Sollinger, D. and Derwand, R. and de Wit, C. and Loirand, G. and Pohl, U.},
Title = {Nitric oxide-induced decrease in calcium sensitivity of resistance arteries is attributable to activation of the myosin light chain phosphatase and antagonized by the RhoA/Rho kinase pathway},
Journal = {Circulation},
Volume = {107},
Number = {24},
Pages = {3081-7},
Note = {1524-4539
Journal Article},
Abstract = {BACKGROUND: NO-induced dilations in resistance arteries (RAs) are not associated with decreases in vascular smooth muscle cell Ca$^{2+}$. We tested whether a cGMP-dependent activation of the smooth muscle myosin light chain phosphatase (MLCP) resulting in a Ca2+ desensitization of the contractile apparatus was the underlying mechanism and whether it could be antagonized by the RhoA pathway. METHODS AND RESULTS: The Ca2+ sensitivity of RA was assessed as the relation between changes in diameter and [Ca2+]i in depolarized RA (120 mol/L K+) exposed to stepwise increases in Ca2+ex (0 to 3 mmol/L). Effects of 10 micromol/L sodium nitroprusside (SNP) on Ca2+ sensitivity were determined before and after application of the soluble guanylate cyclase inhibitor ODQ (1 micromol/L) and the MLCP inhibitor calyculin A (120 nmol/L) and in presence of the RhoA-activating phospholipid sphingosine-1-phosphate (S1P, 12 nmol/L). SNP-induced dilations were also studied in controls and in RAs pretreated with the Rho kinase inhibitor Y27632 or transfected with a dominant-negative RhoA mutant (N19RhoA). Constrictions elicited by increasing Ca2+ex were significantly attenuated by SNP, which, however, left associated increases in [Ca2+]i unaffected. This NO-induced attenuation was blocked by ODQ, calyculin A, and S1P. The S1P-induced translocation of RhoA indicating activation of the GTPase was not reversed by SNP. Inhibition of RhoA/Rho kinase by N19RhoA or Y27632 significantly augmented SNP-induced dilations. CONCLUSIONS: NO dilates RA by activating the MLCP in a cGMP-dependent manner, thereby reducing the apparent Ca2+ sensitivity of the contractile apparatus. MLCP inactivation via the RhoA/Rho kinase pathway antagonizes this Ca2+-desensitizing effect that, in turn, can be restored using RhoA/Rho kinase inhibitors.},
Keywords = {ADP Ribose Transferases/biosynthesis/genetics/pharmacology
Animals
Arteries/*drug effects/physiology
Botulinum Toxins/biosynthesis/genetics/pharmacology
Calcium/*pharmacology
Cyclic GMP/metabolism
Enzyme Inhibitors/pharmacology
Female
Hamsters
In Vitro
*Lysophospholipids
Muscles/blood supply
Mutagenesis, Site-Directed
Myosin-Light-Chain Phosphatase
Nitric Oxide/*pharmacology
Phosphoprotein Phosphatase/antagonists & inhibitors/*metabolism
Protein-Serine-Threonine Kinases/drug effects/*metabolism
Signal Transduction/drug effects/physiology
Sphingosine/*analogs & derivatives/pharmacology
Transfection
Vascular Patency/drug effects/physiology
Vascular Resistance/drug effects/physiology
Vasoconstriction/drug effects/physiology
Vasoconstrictor Agents/pharmacology
Vasodilator Agents/pharmacology
rhoA GTP-Binding Protein/drug effects/genetics/*metabolism},
Year = {2003} }


...falls es hilft

[rais]

Funktioniert leider nicht....
was?


Title = {Nitric oxide-induced decrease in calcium sensitivity of resistance arteries is attributable to activation of the myosin light chain phosphatase and antagonized by the RhoA/Rho kinase pathway},



setz' den Teil `RhoA/Rho' mal in geschweifte Klammern

hier angewendet:


Title = {Nitric oxide-induced decrease in calcium sensitivity of resistance arteries is attributable to activation of the myosin light chain phosphatase and antagonized by the {RhoA/Rho} kinase pathway},

irgend etwas versteh' ich bestimmt wieder nicht :rolleyes:
MfG,

[Fenchurch]

Title = {Nitric oxide-induced decrease in calcium sensitivity of resistance arteries is attributable to activation of the myosin light chain phosphatase and antagonized by the {R}ho{A}/{R}ho kinase pathway}

Sorry... Habs falsch reinkopiert.... funktioniert leider nicht....

[rais]

Title = {Nitric oxide-induced decrease in calcium sensitivity of resistance arteries is attributable to activation of the myosin light chain phosphatase and antagonized by the {R}ho{A}/{R}ho kinase pathway}

Sorry... Habs falsch reinkopiert.... funktioniert leider nicht....
hast Du auch bibtex mit laufen lassen? Bei mir tut's wie's soll...
Sonst erstell bitte ein reproduzierbares Minimalbeispiel.


Außerdem sollte der letze Satz: 1524-4539 Journal Article. nicht dabei stehen.

den hast Du extra als "Note" angegeben -- nenn den Eintrag "xNote", dann taucht er nicht mehr auf bzw. wird ignoriert.
MfG,

[Fenchurch]

oh.. ja da war doch was.... funktioniert einwandfrei, auch das mit "xNote"

Tschuldigung... und vielen Dank!!!